查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405758

qPCR 设备市场规模、份额、趋势分析报告：按测试类型、地区、细分市场预测，2023-2030 年

qPCR Instruments Market Size, Share & Trends Analysis Report By Test Type (7500, QuantStudio Dx, QuantStudio 5, ViiA 7 Dx, One Step/One Step Plus, LightCycler 2.0, Cobas 4800, CFX96, SmartCycler), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10个工作天内

价格

qPCR设备市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，到2030年，全球qPCR设备市场规模预计将达到16.4亿美元。

预计2023年至2030年复合年增长率为7.0%。该市场是由新颖和先进产品的推出以及对高效诊断设备不断增长的需求所推动的。

全球 SARS-CoV-2 感染发病率迅速上升，推动了对 qPCR 设备和用品的需求。发病率上升预计会增加预防性筛检的数量。这是因为各国无法在不进行筛检的情况下确定 COVID-19 患者的数量。

三种基本分子检测的小型化有望提高诊断结果的准确性和特异性，从而增加对分子诊断产品的需求。这些改进预计将使 POC 分子诊断测试更容易获得，并提供更快、更有效的测试结果。例如，Biomolecular Systems 的 Mic qPCR 系统重量仅为 2 公斤，非常便携且易于操作。

QuantStudio 5 Dx 即时 PCR 系统等新推出的产品为消费者提供了改进的工作流程和大容量测试，以更快地提供结果。成本效益和简化的软体提供了更多优势。此外，该设备在 50 多个国家获得核准也促进了市场成长。该设备还配备了伴同性诊断研究的功能，提高了其竞争力。

由于存在高度先进且更准确的数位 PCR 设备，该市场面临外部替代品的高度威胁。由于市场上有大量产品，内部替代品的威胁很大。然而，由于这些设备的价格较高，整体威胁预计将减少并保持在中等水平。

COVID-19 增加了诊断设备的机会。然而，先进的 PCR 技术（如 dPCR）在新兴经济体中更受青睐，因为它们有助于降低假阳性率。研究开发高效 qPCR 设备可以减少设备替代品的威胁并促进市场成长。

近年来，PCR在灵敏度、准确性、效率和成本效益方面取得了技术进步。主要企业正在引入新技术以保持竞争力。

qPCR 设备市场报告亮点

  • GeneXpert 细分市场在 2022 年占据最大的销售份额，为 21.67%。这是由于 SARS-CoV-2 大流行期间感染检测的采用率提高。
  • Rotor-Gene Q 5Plex HRM 系统可在短短 90 分钟内产生结果，比许多其他 qPCR 仪器更快。
  • 北美主导全球qPCR设备市场，2022年占最大销售份额，达42.73%。该地区的成长得益于监管支持的增加和新产品发布的增加。
  • 预计亚太地区在预测期内将以 8.9% 的最快复合年增长率成长。未满足的医疗需求中的开拓机会、不断增加的科学研究倡议以及积极的经济成长是该市场的主要成长动力。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 qPCR 设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • qPCR设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 qPCR 设备：测试类型的估计和趋势分析

  • qPCR 设备市场：重点
  • qPCR 仪器市场：2022 年和 2030 年趋势和市场占有率分析
  • 7500
  • Quant Studio Dx
  • Quant Studio 5
  • ViiA 7 Dx
  • One Step/One Step Plus
  • LightCycler 2.0
  • Cobas 4800
  • CFX96
  • SmartCycler
  • GeneXpert
  • Rotor-Gene Q 5Plex HRM System
  • Rotor-Gene Q
  • BIOFIRE FILMARRAY System
  • BMS Mic System

第五章 qPCR 设备市场：区域估计与趋势分析

  • 区域展望
  • qPCR 仪器市场（按地区）：重点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • BIOMERIEUX
    • Quantabio
    • Azure Biosystems Inc.
    • Bio Molecular Systems
Product Code: GVR-4-68038-339-3

qPCR Instruments Market Growth & Trends:

The global qPCR instruments market size is expected to reach USD 1.64 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.0% from 2023 to 2030. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

qPCR Instruments Market Report Highlights:

  • The GeneXpert segment accounted for the largest revenue share of 21.67% in 2022. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic to detect infections.
  • The Rotor-Gene Q 5Plex HRM System segment is expected to grow at the fastest CAGR of 8.8% during the forecast period owing to the factors such as Rotor-Gene Q 5Plex HRM System can deliver results in as little as 90 minutes, which is faster than many other qPCR instruments.
  • North America dominated the global qPCR instruments market and accounted for the largest revenue share of 42.73% in 2022. The growth of this region is attributed to the growing regulatory support and increasing launches of novel products.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.9% over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. qPCR Instruments Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. qPCR Instruments Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. qPCR Instruments: Test Type Estimates & Trend Analysis

  • 4.1. qPCR Instruments Market: Key Takeaways
  • 4.2. qPCR Instruments Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. 7500
    • 4.3.1. 7500 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. QuantStudio Dx
    • 4.4.1. Quant Studio Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. QuantStudio 5
    • 4.5.1. Quant Studio 5 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. ViiA 7 Dx
    • 4.6.1. ViiA 7 Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. One Step/One Step Plus
    • 4.7.1. One Step/One Step Plus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. LightCycler 2.0
    • 4.8.1. Light Cycler 2.0 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Cobas 4800
    • 4.9.1. Cobas 4800 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. CFX96
    • 4.10.1. CFX96 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. SmartCycler
    • 4.11.1. Smart Cycler market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. GeneXpert
    • 4.12.1. GeneXpert market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Rotor-Gene Q 5Plex HRM System
    • 4.13.1. Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Rotor-Gene Q
    • 4.14.1. Rotor-Gene Q market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. BIOFIRE FILMARRAY System
    • 4.15.1. BIOFIRE FILMARRAY Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. BMS Mic System
    • 4.16.1. BMS Mic System market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. qPCR Instruments Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. qPCR Instruments Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Regulatory Framework/Reimbursement Structure
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Regulatory Framework/Reimbursement Structure
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Denmark
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Thermo Fisher Scientific, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. F. Hoffmann-La Roche Ltd.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Bio-Rad Laboratories, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Danaher
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. QIAGEN
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Agilent Technologies, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Abbott
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. BIOMERIEUX
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Quantabio
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Azure Biosystems Inc.
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Bio Molecular Systems
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 5 Canada qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 6 Europe qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 7 Europe qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 9 UK qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 10 France qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 11 Italy qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 12 Spain qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Denmark qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 14 Sweden qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 15 Norway qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 19 China qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 20 India qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 21 Australia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Thailand qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 23 South Korea qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 24 Latin America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Latin America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 27 Mexico qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 28 Argentina qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 33 UAE qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait qpcr instruments market, by test type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 qPCR instruments: Market outlook
  • Fig. 8 qPCR instruments: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 qPCR instruments market driver impact
  • Fig. 13 qPCR instruments market restraint impact
  • Fig. 14 qPCR instruments market strategic initiatives analysis
  • Fig. 15 qPCR instruments market: Test Type movement analysis
  • Fig. 16 qPCR instruments market: Test Type outlook and key takeaways
  • Fig. 17 7500 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 QuantStudio Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 QuantStudio 5 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 ViiA 7 Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 One Step/One Step Plus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 LightCycler 2.0 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cobas 4800 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 CFX96 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 SmartCycler market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 GeneXpert market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Rotor-Gene Q market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 BIOFIRE FILMARRAY SYSTEMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 BMS Mic System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global qPCR instruments market: Regional movement analysis
  • Fig. 32 Global qPCR instruments market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)